These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 8381087)
1. Suppression of normal human hematopoiesis by cytomegalovirus in vitro. MacKintosh FR; Adlish J; Hall SW; St Jeor S; Smith E; Tavassoli M; Zanjani ED Exp Hematol; 1993 Feb; 21(2):243-50. PubMed ID: 8381087 [TBL] [Abstract][Full Text] [Related]
2. Effect of human cytomegalovirus on proliferation of hematopoietic progenitor cells of cord blood. Liu WJ; Jin RM; Fu XD; Liu B; Guo QL; Deng ZH Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):85-9. PubMed ID: 16613695 [TBL] [Abstract][Full Text] [Related]
3. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro. Mamus SW; Oken MM; Zanjani ED Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887 [TBL] [Abstract][Full Text] [Related]
4. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026 [TBL] [Abstract][Full Text] [Related]
5. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors. Holmberg LA; Miller BA; Ault KA J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368 [TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568 [TBL] [Abstract][Full Text] [Related]
7. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183 [TBL] [Abstract][Full Text] [Related]
9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates. Gallicchio VS; Casale GP; Watts T Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410 [TBL] [Abstract][Full Text] [Related]
11. Infection and replication of human cytomegalovirus in bone marrow stromal cells: effects on the production of IL-6, MIP-1alpha, and TGF-beta1. Taichman RS; Nassiri MR; Reilly MJ; Ptak RG; Emerson SG; Drach JC Bone Marrow Transplant; 1997 Mar; 19(5):471-80. PubMed ID: 9052914 [TBL] [Abstract][Full Text] [Related]
12. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro. Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945 [TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of hematopoiesis by HNK1, DR-positive T cells and monocytes after allogeneic bone marrow transplantation. Vinci G; Vernant JP; Cordonnier C; Henri A; Breton-Gorius J; Rochant H; Vainchenker W Exp Hematol; 1987 Jan; 15(1):54-64. PubMed ID: 3096756 [TBL] [Abstract][Full Text] [Related]
14. Study of possible correlations between in vitro growth of bone marrow stromal and hematopoietic precursor cells early after allogeneic bone marrow transplantation. van den Berg H; van Tol MJ; Waaijer JL; Oudeman-Gruber NJ; Vossen JM Exp Hematol; 1992 Feb; 20(2):184-91. PubMed ID: 1544387 [TBL] [Abstract][Full Text] [Related]
15. Transient erythroblastopenia of childhood. Evidence for cell-mediated suppression of erythropoiesis. Tamary H; Kaplinsky C; Shvartzmayer S; Umiel T; Pecht M; Levin S; Zaizov R Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):386-91. PubMed ID: 8214360 [TBL] [Abstract][Full Text] [Related]
16. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340 [TBL] [Abstract][Full Text] [Related]
17. HLA-DR restriction in suppression of hematopoiesis by T cells from allogeneic bone marrow transplants. Vinci G; Vernant JP; Cordonnier C; Bracq C; Rochant H; Breton-Gorius J; Vainchenker W J Immunol; 1986 May; 136(9):3225-30. PubMed ID: 2937841 [TBL] [Abstract][Full Text] [Related]
18. Role of natural killer cells, in comparison with T lymphocytes and monocytes, in the regulation of normal human megakaryocytopoiesis in vitro. Gewirtz AM; Xu WY; Mangan KF J Immunol; 1987 Nov; 139(9):2915-24. PubMed ID: 3117880 [TBL] [Abstract][Full Text] [Related]
19. Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells. Fujimori Y; Hara H; Nagai K Cancer Res; 1988 Feb; 48(3):534-8. PubMed ID: 3257166 [TBL] [Abstract][Full Text] [Related]